Yifan Pharmaceutical Co., Ltd. (002019.SZ) reported earnings for first quarter that Dropped, from the same period last year
The company's bottom line came in at RMB106.82 million, or RMB0.0878 per share. This compares with RMB153.16 million, or RMB0.1259 per share, last year.
The company's revenue for the period fell 5.4% to RMB1.255 billion from RMB1.326 billion last year.
Yifan Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB106.82 Mln. vs. RMB153.16 Mln. last year.-EPS: RMB0.0878 vs. RMB0.1259 last year.-Revenue: RMB1.255 Bln vs. RMB1.326 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.